PMID- 32315831 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210110 IS - 2589-0042 (Electronic) IS - 2589-0042 (Linking) VI - 23 IP - 4 DP - 2020 Apr 24 TI - Circulating IgGs in Type 2 Diabetes with Atrial Fibrillation Induce IP(3)-Mediated Calcium Elevation in Cardiomyocytes. PG - 101036 LID - S2589-0042(20)30220-0 [pii] LID - 10.1016/j.isci.2020.101036 [doi] LID - 101036 AB - Higher risk of cardiac arrhythmias including atrial fibrillation (AF) associates with type 2 diabetes mellitus (T2DM) with the underlying mechanism largely unknown. The present study reported a subset of circulating immunoglobulin G autoantibodies (IgGs) from patients with T2DM with AF (T2DM/AF)-induced intracellular calcium elevation in both human induced pluripotent stem cell (iPSC)-derived and mouse atrial cardiomyocytes, whereas (identical concentrations of) IgGs from patients with T2DM without AF could not. The IgG-evoked intracellular calcium elevation was insensitive to verapamil, mibefradil, or BTP-2, indicating calcium source from neither voltage-gated calcium channels nor store-operated calcium entry. On the other hand, pharmacological antagonism or genetic knockdown of inositol triphosphate (IP(3)) receptor significantly decreased T2DM/AF IgG-induced intracellular calcium elevation. Furthermore, pharmacological blockage of G protein-coupled receptor (GPCR), heterotrimeric G protein or phospholipase C dampened IgG-induced intracellular calcium elevation. Taken together, circulating IgGs from patients with T2DM/AF stimulated arrhythmogenic intracellular calcium elevation through IP(3) pathway in atrial cardiomyocytes. CI - Copyright (c) 2020 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Luo, Yanhong AU - Luo Y AD - Davis Heart and Lung Research Institute, Ohio State University-Wexner Medical Center, Columbus, OH 43210, USA; Department of Endocrinology, The Children's Hospital of Chongqing Medical University, Chongqing, P. R. China. FAU - Liu, Xian AU - Liu X AD - Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76010, USA; College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA. FAU - Ma, Ruilian AU - Ma R AD - Division of Regenerative Medicine Research, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45219, USA. FAU - Wang, Yigang AU - Wang Y AD - Division of Regenerative Medicine Research, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45219, USA. FAU - Zimering, Mark AU - Zimering M AD - Endocrinology, Veterans Affairs New Jersey Healthcare System, East Orange, NJ 07018, USA; Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA. Electronic address: mark.zimering@va.gov. FAU - Pan, Zui AU - Pan Z AD - Davis Heart and Lung Research Institute, Ohio State University-Wexner Medical Center, Columbus, OH 43210, USA; Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76010, USA; College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA. Electronic address: zui.pan@uta.edu. LA - eng PT - Journal Article DEP - 20200408 PL - United States TA - iScience JT - iScience JID - 101724038 PMC - PMC7170991 OTO - NOTNLM OT - Biological Sciences OT - Cellular Physiology OT - Pathophysiology OT - Physiology COIS- Declaration of Interests The authors declare no competing interests. The contents do not represent the views of the U.S. Department of Veteran Affairs or the United States government. EDAT- 2020/04/22 06:00 MHDA- 2020/04/22 06:01 PMCR- 2020/04/08 CRDT- 2020/04/22 06:00 PHST- 2019/08/30 00:00 [received] PHST- 2020/01/16 00:00 [revised] PHST- 2020/04/01 00:00 [accepted] PHST- 2020/04/22 06:00 [pubmed] PHST- 2020/04/22 06:01 [medline] PHST- 2020/04/22 06:00 [entrez] PHST- 2020/04/08 00:00 [pmc-release] AID - S2589-0042(20)30220-0 [pii] AID - 101036 [pii] AID - 10.1016/j.isci.2020.101036 [doi] PST - ppublish SO - iScience. 2020 Apr 24;23(4):101036. doi: 10.1016/j.isci.2020.101036. Epub 2020 Apr 8.